Multimaterial decomposition in dual-energy CT for characterization of clots from acute ischemic stroke patients
© 2024. The Author(s)..
BACKGROUND: Nowadays, there is no method to quantitatively characterize the material composition of acute ischemic stroke thrombi prior to intervention, but dual-energy CT (DE-CT) offers imaging-based multimaterial decomposition. We retrospectively investigated the material composition of thrombi ex vivo using DE-CT with histological analysis as a reference.
METHODS: Clots of 70 patients with acute ischemic stroke were extracted by mechanical thrombectomy and scanned ex vivo in formalin-filled tubes with DE-CT. Multimaterial decomposition in the three components, i.e., red blood cells (RBC), white blood cells (WBC), and fibrin/platelets (F/P), was performed and compared to histology (hematoxylin/eosin staining) as reference. Attenuation and effective Z values were assessed, and histological composition was compared to stroke etiology according to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.
RESULTS: Histological and imaging analysis showed the following correlation coefficients for RBC (r = 0.527, p < 0.001), WBC (r = 0.305, p = 0.020), and F/P (r = 0.525, p < 0.001). RBC-rich thrombi presented higher clot attenuation in Hounsfield units than F/P-rich thrombi (51 HU versus 42 HU, p < 0.01). In histological analysis, cardioembolic clots showed less RBC (40% versus 56%, p = 0.053) and more F/P (53% versus 36%, p = 0.024), similar to cryptogenic clots containing less RBC (34% versus 56%, p = 0.006) and more F/P (58% versus 36%, p = 0.003) than non-cardioembolic strokes. No difference was assessed for the mean WBC portions in all TOAST groups.
CONCLUSIONS: DE-CT has the potential to quantitatively characterize the material composition of ischemic stroke thrombi.
RELEVANCE STATEMENT: Using DE-CT, the composition of ischemic stroke thrombi can be determined. Knowledge of histological composition prior to intervention offers the opportunity to define personalized treatment strategies for each patient to accomplish faster recanalization and better clinical outcomes.
KEY POINTS: • Acute ischemic stroke clots present different recanalization success according to histological composition. • Currently, no method can determine clot composition prior to intervention. • DE-CT allows quantitative material decomposition of thrombi ex vivo in red blood cells, white blood cells, and fibrin/platelets. • Histological clot composition differs between stroke etiology. • Insights into the histological composition in situ offer personalized treatment strategies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
European radiology experimental - 8(2024), 1 vom: 05. Apr., Seite 52 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gassenhuber, Melina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9001-31-4 |
|---|
| Anmerkungen: |
Date Completed 08.04.2024 Date Revised 08.04.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s41747-024-00443-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370651197 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370651197 | ||
| 003 | DE-627 | ||
| 005 | 20240408233023.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240405s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s41747-024-00443-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1369.xml |
| 035 | |a (DE-627)NLM370651197 | ||
| 035 | |a (NLM)38575701 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gassenhuber, Melina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multimaterial decomposition in dual-energy CT for characterization of clots from acute ischemic stroke patients |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.04.2024 | ||
| 500 | |a Date Revised 08.04.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a BACKGROUND: Nowadays, there is no method to quantitatively characterize the material composition of acute ischemic stroke thrombi prior to intervention, but dual-energy CT (DE-CT) offers imaging-based multimaterial decomposition. We retrospectively investigated the material composition of thrombi ex vivo using DE-CT with histological analysis as a reference | ||
| 520 | |a METHODS: Clots of 70 patients with acute ischemic stroke were extracted by mechanical thrombectomy and scanned ex vivo in formalin-filled tubes with DE-CT. Multimaterial decomposition in the three components, i.e., red blood cells (RBC), white blood cells (WBC), and fibrin/platelets (F/P), was performed and compared to histology (hematoxylin/eosin staining) as reference. Attenuation and effective Z values were assessed, and histological composition was compared to stroke etiology according to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria | ||
| 520 | |a RESULTS: Histological and imaging analysis showed the following correlation coefficients for RBC (r = 0.527, p < 0.001), WBC (r = 0.305, p = 0.020), and F/P (r = 0.525, p < 0.001). RBC-rich thrombi presented higher clot attenuation in Hounsfield units than F/P-rich thrombi (51 HU versus 42 HU, p < 0.01). In histological analysis, cardioembolic clots showed less RBC (40% versus 56%, p = 0.053) and more F/P (53% versus 36%, p = 0.024), similar to cryptogenic clots containing less RBC (34% versus 56%, p = 0.006) and more F/P (58% versus 36%, p = 0.003) than non-cardioembolic strokes. No difference was assessed for the mean WBC portions in all TOAST groups | ||
| 520 | |a CONCLUSIONS: DE-CT has the potential to quantitatively characterize the material composition of ischemic stroke thrombi | ||
| 520 | |a RELEVANCE STATEMENT: Using DE-CT, the composition of ischemic stroke thrombi can be determined. Knowledge of histological composition prior to intervention offers the opportunity to define personalized treatment strategies for each patient to accomplish faster recanalization and better clinical outcomes | ||
| 520 | |a KEY POINTS: • Acute ischemic stroke clots present different recanalization success according to histological composition. • Currently, no method can determine clot composition prior to intervention. • DE-CT allows quantitative material decomposition of thrombi ex vivo in red blood cells, white blood cells, and fibrin/platelets. • Histological clot composition differs between stroke etiology. • Insights into the histological composition in situ offer personalized treatment strategies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Blood coagulation | |
| 650 | 4 | |a Ischemic stroke | |
| 650 | 4 | |a Thrombectomy | |
| 650 | 4 | |a Thrombosis | |
| 650 | 4 | |a Tomography (x-ray computed) | |
| 650 | 7 | |a Fibrin |2 NLM | |
| 650 | 7 | |a 9001-31-4 |2 NLM | |
| 700 | 1 | |a Lochschmidt, Maximilian E |e verfasserin |4 aut | |
| 700 | 1 | |a Hammel, Johannes |e verfasserin |4 aut | |
| 700 | 1 | |a Boeckh-Behrens, Tobias |e verfasserin |4 aut | |
| 700 | 1 | |a Ikenberg, Benno |e verfasserin |4 aut | |
| 700 | 1 | |a Wunderlich, Silke |e verfasserin |4 aut | |
| 700 | 1 | |a Liesche-Starnecker, Friederike |e verfasserin |4 aut | |
| 700 | 1 | |a Schlegel, Jürgen |e verfasserin |4 aut | |
| 700 | 1 | |a Pfeiffer, Franz |e verfasserin |4 aut | |
| 700 | 1 | |a Makowski, Marcus R |e verfasserin |4 aut | |
| 700 | 1 | |a Zimmer, Claus |e verfasserin |4 aut | |
| 700 | 1 | |a Riederer, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Pfeiffer, Daniela |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European radiology experimental |d 2017 |g 8(2024), 1 vom: 05. Apr., Seite 52 |w (DE-627)NLM283556358 |x 2509-9280 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2024 |g number:1 |g day:05 |g month:04 |g pages:52 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s41747-024-00443-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2024 |e 1 |b 05 |c 04 |h 52 | ||